Serum concentrations of S100A8/S100A9 are a reliable biomarker for monitoring disease activity in psoriasis but also rheumatoid arthritis, psoriatic arthritis or infections underlining their clinical relevance (5, 15, 18, 50). This evidence concerns the gene S100A8 and infection.